Assessment of the Effect of Non-surgical Periodontal Treatment on Endothelial Function- a Prospective Study
1 other identifier
observational
40
1 country
1
Brief Summary
An association between periodontitis and endothelial dysfunction has been reported, suggesting that periodontitis presents an inflammatory burden to the cardiovascular system, that might lead to AVD. The study aims aim to assess whether non-surgical periodontal therapy enhances endothelial function in periodontitis patients using a non-invasive diagnostic device to assess endothelial function through PWA and the assessment of levels of salivary Endothelin-1, in a population of people in the UAE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
January 10, 2023
CompletedFirst Posted
Study publicly available on registry
January 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedJanuary 25, 2023
January 1, 2023
1.2 years
January 10, 2023
January 21, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
pulse wave amplitude
2 months
Study Arms (2)
Test
Periodontitis patients
Control
Periodontally healthy patients
Interventions
Assessment of pulse wave amplitude (PWA) through peripheral arterial tonometry (PAT) using the device EndoPAT (Itamar Medical)
assessment the levels of salivary Nitric Oxide using a Nitric Oxide colorimetric detection kit,
Eligibility Criteria
Patients recruited from the pool of patients consulting at Postgraduate teachingb clinics of the University Dental Hospital Sharjah
You may qualify if:
- Group 1: periodontally healthy subjects.
- Group 2: patients with periodontitis stage III or IV and grades A,B or C.
You may not qualify if:
- Medical conditions: Diabetes,pregnancy,obesity,renal disease,patients with cardiovascular diseases including hypertension,recent myocardial infarction or unstable angina (within 3 months),congestive heart failure,valvular heart disease
- Heavy smokers(\>10 cigarettes per day),
- Regular administration of drugs resulting in gingival hyperplasia,root planning in the past 6 months
- Regular administration of drugs resulting in gingival hyperplasia (such as cyclosporine and phenytoin)
- Recent antibiotic use (in the past 3 months)
- Non-surgical periodontal therapy in the past 6 monthsp
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Dental Hospital Sharjah
Sharjah city, United Arab Emirates
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Zahi Badran
University of Sharjah
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 10, 2023
First Posted
January 20, 2023
Study Start
October 1, 2022
Primary Completion
December 1, 2023
Study Completion
June 1, 2024
Last Updated
January 25, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share